Posts by: admin

admin

November 25, 2014November 25, 2014

Study Evaluated CT Tumor Size and Density as Predictors of Response And Outcome in Advanced Melanoma

News

In a recent study titled “Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome”, published in the Journal ... Read more

November 24, 2014November 24, 2014

Study Finds IL28B Polymorphism In Melanoma Patients Is Not A Predictor For Interferon Alpha Treatment

News

In a recent study titled “IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma”, published in PlosOne, a team of researchers led by Dr. Katharina Grabmeier-Pfistershammer, ... Read more

November 21, 2014November 21, 2014

Study Finds Interactions Between UV Light and Genetic Variants Determinant For Childhood Nevus and Freckles

News

In a recent study titled “Interactions between Ultraviolet Light andMC1R and OCA2 Variants Are Determinants of Childhood Nevus and Freckle Phenotypes”, published in the Cancer Epidemiology, Biomarkers & Prevention journal, a research team ... Read more

November 20, 2014

Study Evaluates Solar Elastosis And Cutaneous Melanoma

News

In a recent study titled “Solar elastosis and cutaneous melanoma: a site-specific analysis”, published ahead of print in the International Journal of Cancer, a research team led by Dr. David ... Read more

November 17, 2014November 17, 2014

Bristol-Myers Immunotherapy Opdivo Shows Promising Results In The Treatment Of Advanced Melanoma

News

During the Society for Melanoma Research 2014 International Congress in Zurich, Switzerland, Bristol-Myers Squibb (BMS) presented the results of its CheckMate-066 trial, a Phase 3 randomized, double-blind study comparing Opdivo (nivolumab) to ... Read more

November 14, 2014

Genetic Testing For Melanoma Risk Could Help With Prevention, According to Study

News

A recent study published in the JAMA Dermatology journal, entitled “Family Risk Discussions After Feedback on Genetic Risk of Melanoma” found that positive information on the genetic risk of melanoma ... Read more

November 11, 2014

OHSU To Host The Community Melanoma Registry

News

Oregon Health & Science University will host a half-day symposium at the OHSU Doernbecher Children’s Hospital to discuss the latest melanoma treatments and hear from melanoma survivors. The OHSU Community ... Read more

November 10, 2014November 10, 2014

Study Finds Discordancy in BRAF Mutations Among Primary And Metastatic Melanoma Lesions

News

One of the commonly used treatments for patients diagnosed with BRAF V600 mutation-positive melanoma with unresectable stage III and IV disease includes selective BRAF inhibitor with or without a MEK ... Read more

November 7, 2014November 7, 2014

OncoSec To Present Latest Clinical Data at Melanoma Bridge 2014

News

During the 2014 Melanoma Bridge meeting in Italy, OncoSec Medical Inc., a company focusing on the development of DNA-based intratumoral cancer immunotherapies, will present its most recent data resultant from ... Read more

November 6, 2014November 6, 2014

Study Finds Combination Treatment Effective For Advanced Melanoma

News

A recent clinical study titled “Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma: A Randomized Clinical Trial” and published in The Journal of the American Medical Association ... Read more

November 5, 2014November 5, 2014

Study Finds Lower Doses of Radiation Therapy Efficient To Treat Uveal Melanomas

News

In a recent study titled “Uveal Melanoma Treated With Iodine-125 Episcleral Plaque: An Analysis of Dose on Disease Control and Visual Outcomes”, published in the International Journal of Radiation Oncology.Biology.Physics, ... Read more

November 4, 2014November 4, 2014

Study Finds Relatives Of Melanoma Patients Positive For CDKN2A Mutations Have Higher Incidence Of Additional Cancers

News

In a recent study titled “Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic ... Read more

November 3, 2014

Lymphoseek Receives FDA Expanded Approval For Use In Melanoma and Breast Cancer Lymphatic Mapping

News

Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc 99m tilmanocept) injection has received a Food and Drug Administration (FDA) expanded approval for the inclusion of lymphatic mapping in solid tumors and sentinel lymph ... Read more

October 31, 2014October 31, 2014

PV-10 Shows Promise In Phase 2 Trial of Advanced Melanoma Patients

News

Recent results from Provectus Biopharmaceuticals investigational drug PV-10 have been published in the Annals of Surgical Oncology. A team of research led by Eric A. Wachter, PhD, CTO of Provectus Biopharmaceuticals, ... Read more

October 30, 2014

Study Finds Biochemotherapy Effective In High-Risk Melanoma Patients

News

A recent report published in the Journal of Clinical Oncology has found that 9 weeks of multiagent biochemotherapy can significantly improve relapse-free survival in patients with high-risk melanoma, when compared ... Read more

October 28, 2014October 28, 2014

UV radiation Can Transform Certain Peptides Into Damaging Reactive States

News

Exposure to near-UV radiation can lead to several diseases such as cataracts and skin cancer, and since peptides and proteins comprise 68% of the dry matter of cells they are ... Read more

October 27, 2014October 27, 2014

Researchers Develop Novel Nanoparticle To Deliver Melanoma Drug

News

Researchers from Penn State College of Medicine have published results in the journal Molecular Cancer Therapeutics, titled “Nanolipolee-007, a Novel Nanoparticle-Based Drug Containing Leelamine for the Treatment of Melanoma”, showing ... Read more

October 24, 2014October 24, 2014

Phase I SBIR Grant Awarded to Radiomedix and Viewpoint MT For Metastatic Melanoma Theranostics

News

RadioMedix, Inc. and Viewpoint Molecular Targeting LLC have been awarded a grant by the Small Business Innovation Research (SBIR) program from the National Cancer Institute. This Phase I award of ... Read more

October 23, 2014October 23, 2014

Study Finds New Subpopulation of Melanoma Cells

News

In a recent study titled “Vascular channels formed by subpopulations of PECAM1+ melanoma cells”, published in Nature Communications, a team of researchers from the University of North Carolina School of Medicine, ... Read more

October 22, 2014October 22, 2014

Study Links Melanoma Thickness To Patient Death Rates

News

Researchers from the QIMR Berghofer Medical Research Institute, Brisbane, Australia, have published a study in the Journal of Investigative Dermatology, titled “More people die from thin melanomas (<1mm) than thick melanomas ... Read more